These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7219206)

  • 1. A complement inhibitor produced by Stachybotrys complementi, nov. sp. K-76, a new species of fungi imperfecti.
    Miyazaki W; Tamaoka H; Shinohara M; Kaise H; Izawa T; Nakano Y; Kinoshita T; Hong K; Inoue K
    Microbiol Immunol; 1980; 24(11):1091-108. PubMed ID: 7219206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade.
    Hong K; Kinoshita T; Miyazaki W; Izawa T; Inoue K
    J Immunol; 1979 Jun; 122(6):2418-23. PubMed ID: 448130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of K-76COOH (MX-1) on immune response: induction of suppressor T-cells by MX-1.
    Toki J; Miyazaki W; Inaba M; Saigo S; Nishino T; Fukuba Y; Good RA; Ikehara S
    Int J Immunopharmacol; 1992 Aug; 14(6):1093-8. PubMed ID: 1428364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a novel C5 inhibitor (K-76 COONa) on tumor cell chemotaxis.
    Bumpers HL; Baum J
    J Lab Clin Med; 1983 Sep; 102(3):421-7. PubMed ID: 6886523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, partial characterisation and complement inhibiting activity of a new glycoprotein from Cuscuta europea.
    Zhelev ZD; Stanilova SA; Carpenter BG
    Biochem Biophys Res Commun; 1994 Jul; 202(1):186-94. PubMed ID: 8037713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, characterization and biological activities of novel triprenyl phenols as pancreatic cholesterol esterase inhibitors produced by Stachybotrys sp. F-1839.
    Sakai K; Watanabe K; Masuda K; Tsuji M; Hasumi K; Endo A
    J Antibiot (Tokyo); 1995 Jun; 48(6):447-56. PubMed ID: 7622428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of complement by a series of substituted 2-aryl-1,3-indandiones: interaction with the fifth component of complement.
    Asghar SS; Siddiqui AH; van der Goot H; Timmerman H
    Mol Immunol; 1986 May; 23(5):459-65. PubMed ID: 3748011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human lymphocyte natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity by K-76 COONa, a reagent that blocks complement activity.
    Hudig D; Redelman D; Minning L; Carine K
    J Immunol; 1984 Jul; 133(1):408-14. PubMed ID: 6725955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clionasterol: a potent inhibitor of complement component C1.
    Cerqueira F; Watanadilok R; Sonchaeng P; Kijjoa A; Pinto M; Quarles van Ufford H; Kroes B; Beukelman C; Nascimento MS
    Planta Med; 2003 Feb; 69(2):174-6. PubMed ID: 12624828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-inhibiting iridoids from Morinda morindoides.
    Cimanga K; Hermans N; Apers S; Van Miert S; Van den Heuvel H; Claeys M; Pieters L; Vlietinck A
    J Nat Prod; 2003 Jan; 66(1):97-102. PubMed ID: 12542353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-inhibiting cucurbitacin glycosides from Picria fel-terrae.
    Huang Y; De Bruyne T; Apers S; Ma Y; Claeys M; Vanden Berghe D; Pieters L; Vlietinck A
    J Nat Prod; 1998 Jun; 61(6):757-61. PubMed ID: 9644059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement.
    Ling M; Piddlesden SJ; Morgan BP
    Clin Exp Immunol; 1995 Dec; 102(3):582-8. PubMed ID: 8536376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for different requirements in physical state for the interaction of lipopolysaccharides with the classical and alternative pathways of complement.
    Wilson ME; Morrison DC
    Eur J Biochem; 1982 Nov; 128(1):137-41. PubMed ID: 6756918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of equine complement activity by polysulfated glycosaminoglycans.
    Rashmir-Raven AM; Coyne CP; Fenwick BW; Gaughan EM; Andrews GA; DeBowes RM
    Am J Vet Res; 1992 Jan; 53(1):87-90. PubMed ID: 1539920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticomplement function of heparin].
    Huang SW
    Sheng Li Ke Xue Jin Zhan; 1984 Oct; 15(4):360-3. PubMed ID: 6544523
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM; Gleich GJ
    J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of a human alternative complement pathway inhibitor from hemolymph of larval fall armyworm (Spodoptera frugiperda).
    D'Cruz OJ; Day NK
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1426-33. PubMed ID: 6477568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of the mediated neutrophil reactivity to Escherichia coli peptidoglycan].
    Azov NA; Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Oct; (10):66-9. PubMed ID: 3911674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
    Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
    Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-inhibiting and anti-inflammatory properties of chlorazole fast pink 2BL.
    Doherty NS
    Clin Exp Immunol; 1981 Feb; 43(2):260-9. PubMed ID: 7273480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.